Success Stories: Manager of R & D Formulations in Virginia in the Field of Pharmaceutical Sciences Has EB-1B Approved in Only 1 Month and 8 Days with No PhD

Client’s Testimonial:

 

Thank you so much for your help. I am very happy.
 


We Received EB1B Approval on June 5th, 2014 for a Manager of R & D Formulations in the Field of Pharmaceutical Sciences (Approval Notice)


General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Manager of R & D Formulations

Petitioner: A private company

Country of Origin: India

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing:  Virginia

Approval Notice Date: June 5, 2014

Processing Time: 1 month, 8 days

 


Case Summary:

At North America Immigration Law Group- WeGreened.com, we recently received an EB1B approval for a Manager of R & D Formulations in the field of Pharmaceutical Sciences. The beneficiary’s outstanding ability, highly skilled background, and impressive record of achievement provided a strong case for his EB1B petition. His research had focused on product development research for pharmaceutical products, with demonstrated excellence in drug delivery research and product formulation. His work had resulted in 4 peer-reviewed scientific articles and at least two conference presentations; this work had been cited 87 times at the time that we filed the case by researchers around the world, thus signifying the international recognition and prevalent dissemination of his research work.  In addition, he had served as reviewer and editor for several national and international journals and as a screener for numerous conference abstracts. The petitioner in this case was a private company. His superior level of achievement was confirmed in the following quote by an independent recommender, “[He] has consistently displayed excellence in research, which has had a notable and positive impact on the field of pharmaceutical science both nationally and internationally. It is certain that he will continue to benefit research and industry in the pharmaceutical sciences in the future. Because I have personally utilized his reputable and reliable expertise in my own work, I have experienced firsthand the importance of [his] research in designing better drug delivery platforms for the best possible medical treatment.”  It was our goal to prove that this beneficiary qualified for classification as an outstanding professor or researcher given the international recognition for his outstanding achievements.  His petition was approved in just 1 month and 8 days.